Fingerprint
Dive into the research topics of 'A multicenter, open-label phase II clinical trial of combined MEK plus EGFR inhibition for chemotherapy-refractory advanced pancreatic adenocarcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically